Plandai Biotechnology, Inc. Molecularly Changing the Botanical Extract Industry
May 08, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 8, 2013) - That loud noise coming from the botanical extract industry is Plandaí Biotechnology, Inc. (OTCQB: PLPL) landing on the scene with three highly...
Stock House Group Report Initiates Coverage on Plandai Biotechnology, Inc.
May 01, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 1, 2013) - After careful analysis, Stock House Group, a full service research and content development investor relations firm, has initiated coverage and placed a...
Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S.
April 16, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 16, 2013) - With more and more acceptance of medical marijuana here in the U.S., companies like Nuvilex, Inc. (OTCQB: NVLX), and research centers like the...
Nuvilex, Inc. Can Benefit From Passage of This Week's Medical Marijuana Bill
April 10, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its subsidiary Medical Marijuana Sciences, Inc. received some good news this week as Maryland lawmakers passed a bill...
Nuvilex, Inc. Expects its Technology Can Start to Change Life for Diabetics
April 08, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 8, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) started its diabetes studies, it was likely well known then that while its late-stage pancreatic cancer trials are front...
Nuvilex, Inc. Phase III Clinical Trials in Strong Hands With Dr. Gerald Crabtree
April 01, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Apr 1, 2013) - Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing two years ago when he announced Dr. Gerald Crabtree would be joining his...
Nuvilex, Inc. Diabetes Studies Could Eliminate Need for Daily Insulin Requirements
March 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 18, 2013) - When investors look into biotechnology and pharmaceutical companies as an investment opportunity, three areas of research stand out as the most favorable...